glp-1 therapies success rate Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes The Impact of GLP-1 Agonists

( 10.1016/j.molmet.2019.09.010) [DOI] [PMC free article] [PubMed] [Google Scholar] 3.Nauck MA, Heimesaat MM, Behle K, Holst JJ, Nauck MS, Ritzel R, Hfner M, Schmiegel WH

The six-month study showed that patients who stuck to their medication (95% adherence at three months), regularly did strength training, and ate enough protein were more successful at preserving muscle mass

10 Recently, several clinical trials have shown the potential effects of these medications in not only in glycemic control but also in the improvement of cardiovascular outcomes, weight loss, osteoarthritis, 11 metabolic dysfunctionassociated steatohepatitis (MASH), 12 Parkinsons disease, 13 chronic kidney disease (CKD) 14 and obstructive sleep apnea

The GLP-1 and alcohol connection may represent one of the most significant breakthroughs in addiction neuroscience in decades

If you have tried other weight loss methods but failed to get the weight off or keep it off, weight loss injections may be helpful

The presence of the receptor in the brain would also explain the apparent effects of GLP-1RAs in curbing addictive behaviors (2426)